Director John Hatsopoulos filed a Form 4 with the SEC on November 20, 2026, disclosing three open-market purchases of Tecogen Inc. common stock on November 19, 2026.

Key Highlights

  • Three purchases on one day: Hatsopoulos acquired 2,000 shares at $1.72, 1,000 shares at $1.685, and 2,000 shares at $1.705, all on November 19, 2026.
  • Total shares acquired: 5,000 shares of Tecogen Inc. common stock across the three transactions, according to the filing.
  • Resulting ownership: Following the reported transactions, Hatsopoulos directly beneficially owns 1,043,951 shares of common stock, the filing states.
  • Transaction code: All three transactions are coded "P" (open-market purchase) in the filing.
  • Role: The filing identifies Hatsopoulos as a Director of Tecogen Inc., traded on NASDAQ:TGEN.

Hatsopoulos Adds to Direct Stake in Tecogen With November 19 Purchases

According to the Form 4 filed on November 20, 2026, John Hatsopoulos, a director of Tecogen Inc. (NASDAQ:TGEN), reported three separate purchases of the company's common stock executed on November 19, 2026. The transactions were each coded "P," indicating open-market purchases, and all shares are held directly by the reporting person.

The filing details the following transactions: 2,000 shares acquired at $1.72 per share, bringing his holdings to 1,040,951 shares; 1,000 shares acquired at $1.685 per share, bringing holdings to 1,041,951 shares; and a final purchase of 2,000 shares at $1.705 per share. After all three transactions, the filing reports Hatsopoulos directly beneficially owns 1,043,951 shares of Tecogen Inc. common stock.

No derivative securities transactions were reported in Table II of the filing. The form was signed by John N. Hatsopoulos and dated November 20, 2026. The filing does not indicate that any transaction was made pursuant to a Rule 10b5-1(c) plan, as that checkbox was not selected.

What Was Disclosed

Director John Hatsopoulos disclosed three open-market purchases of Tecogen Inc. common stock on November 19, 2026, totaling 5,000 shares at prices ranging from $1.685 to $1.72, resulting in direct beneficial ownership of 1,043,951 shares.